GlassScriptPhysician profile
Billy J Rosson
NPI 1164414629
$11,144.35
in general payments reported to CMS, 2019-2025
37 companies · $2,255 in 2025
The $2,255 reported for 2025 was more than what 78% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,697 · 2020: $1,147 · 2021: $1,580 · 2022: $1,268 · 2023: $1,418 · 2024: $1,779 · 2025: $2,255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,321 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,320.97 |
| Education | $130.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,335.81 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $1,526.41 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Genzyme Corporation | $895.20 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $808.32 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $651.52 | 2019-2025 | Ofev |
| Insmed, INC. | $460.56 | 2019-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $440.86 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $375.41 | 2019-2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $352.37 | 2019-2024 | Uptravi, Opsumit |
| Amgen INC. | $202.53 | 2022-2025 | Tezspire |
| Mallinckrodt Hospital Products INC. | $196.85 | 2021-2025 | Acthar |
| Genentech USA, INC. | $194.95 | 2019-2023 | Xolair |
| Novartis Pharmaceuticals Corporation | $193.03 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $162.19 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $155.89 | 2024-2025 | Winrevair, Zerbaxa |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $138.57 | 2021-2022 | |
| United Therapeutics Corporation | $136.72 | 2019-2022 | |
| Intuitive Surgical, INC. | $123.76 | 2024 | |
| Gilead Sciences, INC. | $119.71 | 2019-2022 | |
| Electromed, INC. | $71.19 | 2022-2023 | Smartvest |
| Verona Pharma, INC. | $68.10 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $67.49 | 2025 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $65.32 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $60.08 | 2025 | Purified Cortrophin Gel |
| Janssen Pharmaceuticals, INC | $56.40 | 2021 | |
| Allergan, INC. | $46.06 | 2019 | |
| Astellas Pharma US INC | $33.68 | 2021 | |
| Philips North America LLC | $31.71 | 2023-2024 | (Ak6) Vest Therapy |
| Circassia INC. | $28.19 | 2019 | |
| Liquidia Technologies, INC. | $22.60 | 2025 | Yutrepia |
| Sunovion Pharmaceuticals INC. | $20.46 | 2019 | |
| Acacia Pharma INC | $20.29 | 2021 | |
| Pulmonx Corporation | $20.26 | 2021 | |
| Ucb, INC. | $20.06 | 2021 | |
| Livanova USA, INC. | $15.26 | 2020 | |
| Fisher & Paykel Healthcare INC | $14.75 | 2021 | |
| Ekos Corporation | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Billy Rosson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.